BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10935449)

  • 1. Immunohistochemical studies of the PrP(CJD) deposition in Creutzfeldt-Jakob disease.
    Tanaka S; Saito M; Morimatsu M; Ohama E
    Neuropathology; 2000 Jun; 20(2):124-33. PubMed ID: 10935449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal and astrocytic responses involving the serotonergic system in human spongiform encephalopathies.
    Fraser E; McDonagh AM; Head M; Bishop M; Ironside JW; Mann DM
    Neuropathol Appl Neurobiol; 2003 Oct; 29(5):482-95. PubMed ID: 14507340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease.
    Ferrer I; Puig B; Blanco R; Martí E
    Neuroscience; 2000; 97(4):715-26. PubMed ID: 10842016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of sporadic Creutzfeldt-Jakob disease with both plaque and synaptic-type deposition of prion protein.
    Tanaka S; Ota M; Ohama E
    Neuropathology; 2000 Mar; 20(1):49-55. PubMed ID: 10935437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease.
    Manners DN; Parchi P; Tonon C; Capellari S; Strammiello R; Testa C; Tani G; Malucelli E; Spagnolo C; Cortelli P; Montagna P; Lodi R; Barbiroli B
    Neurology; 2009 Apr; 72(16):1425-31. PubMed ID: 19380702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autopsy case of sporadic Creutzfeldt-Jakob disease presenting with signs suggestive of brainstem and spinal cord involvement.
    Iwasaki Y; Iijima M; Kimura S; Yoshida M; Hashizume Y; Yamada M; Kitamoto T; Sobue G
    Neuropathology; 2006 Dec; 26(6):550-6. PubMed ID: 17203592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creutzfeldt-Jakob disease.
    Iwasaki Y
    Neuropathology; 2017 Apr; 37(2):174-188. PubMed ID: 28028861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease.
    Ferrer I
    Cerebellum; 2002 Jul; 1(3):213-22. PubMed ID: 12879983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal phosphorylated RNA-dependent protein kinase in Creutzfeldt-Jakob disease.
    Paquet C; Bose A; Polivka M; Peoc'h K; Brouland JP; Keohane C; Hugon J; Gray F
    J Neuropathol Exp Neurol; 2009 Feb; 68(2):190-8. PubMed ID: 19151623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive microglia in Creutzfeldt-Jakob disease.
    Mühleisen H; Gehrmann J; Meyermann R
    Neuropathol Appl Neurobiol; 1995 Dec; 21(6):505-17. PubMed ID: 8745240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autopsied case of Creutzfeldt-Jakob disease with mutation in the prion protein gene codon 232 and type 1+2 prion protein.
    Iwasaki Y; Yokoi F; Tatsumi S; Mimuro M; Iwai K; Kitamoto T; Yoshida M
    Neuropathology; 2013 Oct; 33(5):568-75. PubMed ID: 23320809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Codistribution of amyloid beta plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype.
    Ghoshal N; Cali I; Perrin RJ; Josephson SA; Sun N; Gambetti P; Morris JC
    Arch Neurol; 2009 Oct; 66(10):1240-6. PubMed ID: 19822779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases).
    Budka H; Aguzzi A; Brown P; Brucher JM; Bugiani O; Gullotta F; Haltia M; Hauw JJ; Ironside JW; Jellinger K
    Brain Pathol; 1995 Oct; 5(4):459-66. PubMed ID: 8974629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathology of variant Creutzfeldt-Jakob disease.
    Ironside JW
    C R Biol; 2002 Jan; 325(1):27-31. PubMed ID: 11862618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MM2-thalamic-type sporadic Creutzfeldt-Jakob disease with widespread neocortical pathology.
    Hirose K; Iwasaki Y; Izumi M; Yoshida M; Hashizume Y; Kitamoto T; Sahashi K
    Acta Neuropathol; 2006 Oct; 112(4):503-11. PubMed ID: 16957926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GluR2/3, NMDAepsilon1 and GABAA receptors in Creutzfeldt-Jakob disease.
    Ferrer I; Puig B
    Acta Neuropathol; 2003 Oct; 106(4):311-8. PubMed ID: 12835949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantitative study of the pathological changes in cortical neurons in sporadic Creutzfeldt-Jakob disease.
    Armstrong RA; Lantos PL; Cairns NJ
    Neuropathology; 2003 Sep; 23(3):181-7. PubMed ID: 14570284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathologic characteristics of spinal cord lesions in sporadic Creutzfeldt-Jakob disease.
    Iwasaki Y; Yoshida M; Hashizume Y; Kitamoto T; Sobue G
    Acta Neuropathol; 2005 Nov; 110(5):490-500. PubMed ID: 16175355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes.
    Ward A; Hollister JR; McNally K; Ritchie DL; Zanusso G; Priola SA
    Acta Neuropathol Commun; 2020 Jun; 8(1):83. PubMed ID: 32517816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease.
    Ironside JW; Head MW
    Curr Top Microbiol Immunol; 2004; 284():133-59. PubMed ID: 15148991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.